report
Mass spectrometry market to rise at 12.26% CAGR through 2028
Thanks to an increased investment in pharmaceutical and biopharmaceuticals.
Mass spectrometry market to rise at 12.26% CAGR through 2028
Thanks to an increased investment in pharmaceutical and biopharmaceuticals.
Global intraocular lens market to grow by $1.17b through 2028
Its expansion is attributed to a rise in ophthalmic diseases, particularly cataracts.
BCH’s FY24 revenue guidance down to mid-single-digit YoY growth
One key factor is the SSO’s reduction in medical service fees for complex treatments.
Prosthetic robot arm market to rise at 14.8% CAGR through 2028
The market is witnessing a trend towards 3D printing technology.
Medical billing outsourcing market to reach $45.8b by 2033
Its growth is attributed to the increasing complexity of healthcare billing processes.
APAC to record fastest growth in global burn care market
One key driver is the expansion of healthcare centres in countries, such as China and India.
Multinational investments to bolster Vietnam's medical device sector
International acquisitions are driving growth in high-margin advanced equipment.
Global heparin market to be valued at $15b by 2030
One key driver is the innovation in drug delivery systems and formulations.
What’s driving the global gastric cancer diagnostics market?
One key trend is the integration of molecular diagnostics such as next-generation sequencing.
Orthokeratology lens market to grow at 6.39% CAGR through 2028
Thanks to an increased demand for non-surgical vision correction alternatives.
Sleep apnea diagnostic systems market to reach $1.3b by 2033
The sector is driven by AI integration and a focus on home monitoring.
APAC local pharmaceutical firms challenge multinational dominance
This development is attributed to increased R&D investments and supportive government policies.
Chularat Hospital net profit dips 7% to $5.6m in Q2
Gross profit margin slipped to 21.51% despite a 10% increase in revenues from hospital operations.
China's LAA closure devices market to grow at 5% CAGR through 2033
The competitive landscape is expected to fuel an increase in research and development investments.
Neurological devices market to be valued at $20.9b by 2033
The sector’s growth is attributed to a rising prevalence of neurological disorders.
APAC to emerge as key player in the global AI oncology market
Its growth is fuelled by rapid technological advancements and increased healthcare investments.
Malaysia’s drugmakers face uncertainty amidst proposed pricing regulations
Pharmaceutical companies’ operations and profitability are likely to be impacted by the initiative.